top of page
CLINICAL TRIALS
BreStem is currently running a Phase 1 Trial on the use of autologous lung stem cells to treat patients with IPF and PF-ILD
Contact: Dr. Jason Lobo, MD, UNC-Chapel Hill
​
bottom of page
BreStem is currently running a Phase 1 Trial on the use of autologous lung stem cells to treat patients with IPF and PF-ILD
Contact: Dr. Jason Lobo, MD, UNC-Chapel Hill
​